Bellevue Centre
Suite 300 235 -15th Street
West Vancouver, BC V7T 2X1
Canada
604 921 1810
https://briacell.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 16
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Dr. William V. Williams M.D. | CEO, President & Director | 785.3k | N/D | 1955 |
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. | CFO & Corporate Secretary | 304.46k | N/D | 1973 |
Dr. Miguel A. Lopez-Lago Ph.D. | Chief Scientific Officer | 298.9k | N/D | 1969 |
Dr. Giuseppe Del Priore M.D., M.P.H., MPH | Chief Medical Officer | 492.5k | N/D | 1962 |
Dr. Charles Louis Wiseman FACP, M.D. | Founder, Principal Research Advisor & Member of Scientific Advisory Board | 241.14k | N/D | 1946 |
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
La calificación ISS Governance QuickScore de BriaCell Therapeutics Corp. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.